Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
NewAmsterdam Pharma Company (NAMS) Ownership Overview
16.67% Insiders
7.62% Mutual Funds
2.64% Other Institutional Investors
0.85% ETFs
72.21% Public Companies and Individual Investors
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail, and individual investors. Approximately 11.11% of the company’s stock is owned by Institutional Investors, 16.67% is owned by Insiders, and 72.21% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 28, 2025 | xxxxxxxxxxxxx | $25515 | |
Mar 06, 2025 | xxxxxxxxxxxxx | $84185 | |
Mar 05, 2025 | xxxxxxxxxxxxx | $3055500 | |
Oct 01, 2024 | xxxxxxxxxxxxx | $707400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $605277 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $11247630 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $16383369 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $49995866 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,656,172 | Insider | 9.49% | 210,459,397 | |
| 10,138,938 | Institution | 9.03% | 200,244,026 | |
| 6,978,534 | Institution | 6.22% | 137,826,047 | |
| 6,814,569 | Insider | 6.07% | 134,587,738 | |
| 6,648,847 | Institution | 5.92% | 131,314,728 | |
| 4,103,957 | Institution | 3.66% | 81,053,151 | |
| 2,442,397 | Institution | 2.18% | 48,237,341 | |
| 2,156,406 | Institution | 1.92% | 42,589,019 | |
| 1,278,646 | Institution | 1.14% | 25,253,259 | |
| 800,360 | Institution | 0.71% | 15,807,110 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,648,847 | Institution | 5.92% | 131,314,728 | |
| 2,156,406 | Institution | 1.92% | 42,589,019 | |
| 1,278,646 | Institution | 1.14% | 25,253,259 | |
| 715,474 | Institution | 0.64% | 14,130,612 | |
| 582,927 | Institution | 0.52% | 11,512,808 | |
| 573,596 | Institution | 0.51% | 11,328,521 | |
| 426,900 | Institution | 0.38% | 8,431,275 | |
| 273,345 | Institution | 0.24% | 5,398,564 | |
| 133,694 | Institution | 0.12% | 2,640,457 | |
| 131,652 | Institution | 0.12% | 2,600,127 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 347,051 | Institution | 0.31% | 6,854,257 | |
| 137,416 | Institution | 0.12% | 2,488,604 | |
| 106,773 | Institution | 0.10% | 2,108,767 | |
| 74,137 | Institution | 0.07% | 1,464,206 | |
| 73,502 | Institution | 0.07% | 1,451,665 | |
| 52,010 | Institution | 0.05% | 1,051,122 | |
| 48,222 | Institution | 0.04% | 952,385 | |
| 31,171 | Institution | 0.03% | 596,301 | |
| 30,873 | Institution | 0.03% | 623,943 | |
| 22,374 | Institution | 0.02% | 452,179 |
FAQ
Who Owns NewAmsterdam Pharma Company (NAMS)?
According to the latest TipRanks data, approximately 2.64% of the company's stock is held by institutional investors, 16.67% is held by insiders, and 72.21% is held by retail investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.64% of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.21% of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors.
Who owns the most shares of NewAmsterdam Pharma Company (NAMS)?
ForGrowth NAP B.V. owns the most shares of NewAmsterdam Pharma Company (NAMS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.